Workboat Indexes
Headline News about Dexcom Inc
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
DexCom (DXCM) Q1 2024 Earnings Call Transcript
April 26, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Peering Into DexCom's Recent Short Interest
April 25, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/02/stock-Dexcom-01-company.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Analyst Verdict: DexCom In The Eyes Of 4 Experts
April 10, 2024
Via Benzinga
![](https://staticx-tuner.zacks.com/images/articles/charts/54/65329.jpg?v=1424768180)
Via Talk Markets
![](https://www.investors.com/wp-content/uploads/2019/01/stock-ResMed-01-shutter.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://investorplace.com/wp-content/uploads/2019/07/techstock1600.jpg)
![](https://www.investors.com/wp-content/uploads/2024/04/A1-041524-glucosemonitoring-Gash.jpg)
![](https://images.pexels.com/photos/187041/pexels-photo-187041.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
DexCom Inc Chart Analysis
March 26, 2024
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-down-red-sell-arrow-bucking-ride-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://g.foolcdn.com/editorial/images/771856/physician-shaking-patients-hand.jpg)
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-to-sell1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/overvalued-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
DexCom's Options: A Look at What the Big Money is Thinking
March 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/01/micron_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/770105/march.jpeg)
![](https://www.investors.com/wp-content/uploads/2020/06/Stock-Diabetes-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.